返回 Agenda
Session Chair(s)
Robert Hemmings, MSC
Critical Path Institute, Netherlands
Speaker(s)
Selecting and Implementing the Right Dose
Frank Bretz, PHD
Novartis , Switzerland
Distinguished Quantitative Research Scientist
Ensuring Alignment on What Treatment Effects Are of Interest to be Estimated in Clinical Trials: New ICH Guidance
Christine Fletcher, MSC
GlaxoSmithKline, United Kingdom
VP/Head, Speciality and Primary Care Statistics
Issues in Designing and Implementing a Clinical Trial in a Healthcare Database: Experiences from the Salford Lung Study
Lucy J Frith, MBA, MSC
Glaxosmithkline, United Kingdom
Director, Clinical Statistics, Respiratory